SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 27, 17:00
3380.95
-104.9 (-3.01%)
VOLUME 19,454
LIVE
NSE
Apr 27, 17:00
3385.60
-98.55 (-2.83%)
VOLUME 544,699
Announcements on Dr Reddys Labs

23rd-Apr-2015 12:21Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Tarvinder Singh Anand has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

20th-Apr-2015 10:50Source: BSE

Dr Reddys Labs- Shareholding Pattern For March 31, 2015

Dr Reddys Laboratories Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.

17th-Apr-2015 18:20Source: NSE

Dr. Reddy's Laboratories Limited

Satish Reddy has submitted to the Exchange vide letter dated April 08, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2...

15th-Apr-2015 16:26Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

14th-Apr-2015 15:39Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Prabhakaran Nair has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

13th-Apr-2015 15:01Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Krishna Venkatesh has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

7th-Apr-2015 20:05Source: BSE

Dr Reddys Labs- Dr. Reddy's Laboratories and its subsidiary Promius Pharma™ announce the filing of three NDAs with the USFDA

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated April 07, 2015 titled "Dr. Reddy''s Laboratories and its subsidiary Promius Pharma™ announce the filing of three NDAs with...

6th-Apr-2015 19:53Source: BSE

Dr Reddys Labs- FY15 results on May 12, 2015

Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 12, 2015, inter alia, to consider and approve the Audited Financial Results of t...

6th-Apr-2015 13:01Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Abhijit Mukherjee has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

6th-Apr-2015 12:54Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Varanasi Narasimha has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

1 2 3 4 5 Next >>
Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2015-05-12

Audited Results & Dividend

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.